Outpatient Management of Acquired Immunodeficiency Syndrome

  • Richard B. Brown

Abstract

The acquired immunodeficiency syndrome (AIDS) is a recently recognized viral disease that represents one of the major health care problems of the 1980s. “Full-blown” AIDS requires the presence of opportunistic infection or specific malignancy in an individual made at risk by virtue of infection with the human immunodeficiency virus (HIV).1 Recently, this definition has been expanded to include wasting disease and dementia. Several other diseases may also be included if accompanied by evidence of HIV positivity.2 These include extra-pulmonary tuberculosis and recurrent nontyphoidal Salmonella bacteremia. AIDS-related complex (ARC) is noted by the presence of weight loss, persistent lymphadenopathy, fever, and other constitutional complaints in the absence of the infections, malignancies, or other parameters that define AIDS.3 Asymptomatic infection with HIV can also be demonstrated serologically by testing for the presence of either antibodies to the virus or actual viral antigen.4

Keywords

Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Acquire Immunodeficiency Syndrome Pneumocystis Carinii Pneumonia Human Immunodeficiency Virus Testing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Jaffe HW, Bregman DJ, Selik RM: Acquired immune deficiency syndrome in the United States: The first 1,000 cases. J Infect Dis 1983; 148: 339–345.PubMedCrossRefGoogle Scholar
  2. 2.
    Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid Mortal Week Rep 1987; 36: 3S - 15S.Google Scholar
  3. 3.
    Swartz MN: Lymphadenitis and lymphangitis. In: Mandell GL, Douglas RG Jr, Bennett JE, eds. Principles and Practice of Infectious Diseases,ed 2. New York, John Wiley & Sons, 1985:618624.Google Scholar
  4. 4.
    Allain JP, Laurian Y, Paul DA, et al: Long-term evaluation of the HIV antigen and antibodies to p24 and gp41 in patients with hemophilia. N Engl J Med 1987; 317: 1114–1121.PubMedCrossRefGoogle Scholar
  5. 5.
    Centers for Disease Control: Update: Acquired immunodeficiency syndrome and human immunodeficiency virus infection among health care workers. Morbid Mortal Week Rep 1988; 37: 229234.Google Scholar
  6. 6.
    Coolfont Report: A PHS plan for prevention and control of AIDS and the AIDS virus. Public Health Rep 1986; 101: 341–348.Google Scholar
  7. 7.
    Centers for Disease Control: Public health guidelines for counseling and antibody testing to prevent HIV infection and AIDS. Morbid Mortal Week Rep. 1987; 36: 509–515.Google Scholar
  8. 8.
    Goedert JJ, Biggar RJ, Weiss SH, et al: Three-year incidence of AIDS in five cohorts of HTLVIII-infected risk group members. Science 1986; 231: 992–995.PubMedCrossRefGoogle Scholar
  9. 9.
    Hardy AM, Rauch K, Echenberg D, et al: The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. JAMA 1986; 255: 209–211.Google Scholar
  10. 10.
    Centers for Disease Control: Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. Morbid Mortal Week Rep 1987; 36: 509–515.Google Scholar
  11. 11.
    Ross MW: Social and behavioral aspects of male homosexuality. Med. Clin North Am 1986; 70: 537–547.PubMedGoogle Scholar
  12. 12.
    Curran JW, Morgan WM, Hardy AM, et al: The epidemiology of AIDS: Current status and future prospects. Science 1985; 229: 1352–1358.PubMedCrossRefGoogle Scholar
  13. 13.
    Selwyn PA: AIDS: What is now known, III. Clinical aspects. Hosp. Pract 1906; 21: 119–153.Google Scholar
  14. 14.
    Vendrell J, Geredia C, Pujol M, et al: Guillain-Barre syndrome associated with seroconversion for acute HTLV-III. Neurology (NY) 1987; 37: 544.Google Scholar
  15. 15.
    Abrams DI: Lymphadenopathy related to the acquired immunodeficiency syndrome in homosexual men. Med Clin North Am 1986; 70: 693–706.PubMedGoogle Scholar
  16. 16.
    Centers for Disease Control: Summary: Recommendations for preventing transmission of infection with human T-lymphotrophic virus type III/lymphadenopathy-associated virus in the workplace. Morbid Mortal Week Rep 1985; 34: 681–695.Google Scholar
  17. 17.
    Abrams DI, Dilley JW, Maxey LM, et al: Routine care and psychosocial support of the patient with the acquired immunodeficiency syndrome. Med Clin North Am 1986; 70: 707–720.PubMedGoogle Scholar
  18. 18.
    Kaslow RA, Phair JP, Friedman HB, et al: Infection with the human immunodeficiency virus: Clinical manifestations and the relationship to immune deficiency. Ann Intern Med 1987; 107: 474–480.PubMedCrossRefGoogle Scholar
  19. 19.
    Goedert JJ, Biggar RJ, Melbye M, et al: Effect of T4 count and cofactors on the incidence of AIDS in homosexual men infected with the human immunodeficiency virus. JAMA 1987; 257: 331–334.Google Scholar
  20. 20.
    Chaisson RE, Allain JP, Leuther M, et al: Decline in serum HIV p 24 antigen (Ag) in patients treated with AZT. In: International Conference on AIDS, 1987Google Scholar
  21. 21.
    Fischl MA, Richman DD, Grieco MH, et al: The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987; 317: 185–191.PubMedCrossRefGoogle Scholar
  22. 22.
    Richman DD, Fischi MA, Grieco MH, et al: The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1987; 317: 192–197.PubMedCrossRefGoogle Scholar
  23. 23.
    Gill PS, Rarick M, Brynes RK, et al: Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1987; 107: 502–502.PubMedCrossRefGoogle Scholar
  24. 24.
    Kovacs JA, Hiemenz JW, Macher AM, et al: Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 1984; 100: 663–671.PubMedCrossRefGoogle Scholar
  25. 25.
    Fauci AS, Macher AM, Longo DL, et al: Acquired immunodeficiency syndrome: Epidemiologic, clinical, immunologic, and therapeutic considerations. Ann Intern Med 1984; 100: 92–106.PubMedCrossRefGoogle Scholar
  26. 26.
    Lerner CW, Tapper ML: Opportunistic infections complicating acquired immune deficiency syndrome. Medicine 1984; 63: 155–164.PubMedCrossRefGoogle Scholar
  27. 27.
    Sands M, Kron MA, Brown RB: Pentamitine: A review. Rev Infect Dis 1985; 7: 625–634.PubMedCrossRefGoogle Scholar
  28. 28.
    Wharton JM, Coleman DL, Wofsy CB, et al: Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 37–44.PubMedCrossRefGoogle Scholar
  29. 29.
    Young LS: Management of opportunistic infections complicating the acquired immunodeficiency syndrome. Med Clin North Am 1986; 70: 677–692.PubMedGoogle Scholar
  30. 30.
    Mills J: Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS. Rev Infect Dis 1986; 8: 1001–1011.CrossRefGoogle Scholar
  31. 31.
    Conte JE, Hollander H, Golden JA: Inhaled or reduced-dose intravenous pentamidine for Pneumocystis carinii pneumonia. Ann Intern Med 1987; 107: 495–498.PubMedCrossRefGoogle Scholar
  32. 32.
    Gordin FM, Simon GL, Wofsy CB, et al: Adverse reactions to trimethoprim-sulfamethoxazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 100: 495–499.PubMedCrossRefGoogle Scholar
  33. 33.
    Medical World News June 8, 1987.Google Scholar
  34. 34.
    Debs RJ, Blumenfeld W, Brunette EN, et al: Successful treatment with aerosolized pentamidine of Pneumocystis carinii pneumonia in rats. Antimicrob Agents Chemother 1987; 31: 37–41.PubMedCrossRefGoogle Scholar
  35. 35.
    Montgomery AB, Debs RC, Corkery LK, et al: Concentration of pentamidine in bronchoalveolar lavage fluid after aerosol and intravenous administration. Am Rev Respir Dis 1987; 135: A167.Google Scholar
  36. 36.
    Bernard EM, Pagel L, Schmitt HJ, et al Clinical trials with aerosol pentamidine for prevention of Pneumocystis carinii pneumonia. Clin Res 1987; 35: 468A.Google Scholar
  37. 37.
    Leoung GS, Mills J, Hopewell PC, et al: Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. Ann Intern Med 1986; 105: 45–48.PubMedCrossRefGoogle Scholar
  38. 38.
    Medina I, Wofsy FD: Cross-allergy to sulfonamides/ sulfones (sulfa) and folic acid antagonists in AIDS. In: 3rd International Conference on AIDS, Washington 1987Google Scholar
  39. 39.
    Dworkin B, Wormser GP, Rosenthal WS, et al: Gastrointestinal manifestations of the acquired immunodeficiency syndrome: A review of 22 cases. Am J Gastroenterol 1985; 80: 774–778.PubMedGoogle Scholar
  40. 40.
    Gelb A, Miller S: AIDS and gastroenterology. Am J Gastroenterol 1986; 81: 619–622.PubMedGoogle Scholar
  41. 41.
    Laurence J: Gastrointestinal infections in AIDS patients. Infect Surg 1986; 5: 651–658.Google Scholar
  42. 42.
    Antony MA, Brandt LJ, Klein RS, et al: Infectious causes of diarrhea in patients with AIDS. In: 3rd International Conference on AIDS, Washington 1987Google Scholar
  43. 43.
    Jacobs JL, Gold JwM, Murray HW, et al: Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1985; 102: 186–188.PubMedCrossRefGoogle Scholar
  44. 44.
    Nadelman RB, Mathur-Wagh U, Yancovitz SR, et al: Salmonella bacteremia associated with the acquired immunodeficiency syndrome (AIDS). Arch Intern Med 1985; 145: 1968–1971.PubMedCrossRefGoogle Scholar
  45. 45.
    Profeta S, Forrester C, Eng RHK, et al: Salmonella infections in patients with acquired immunodeficiency syndrome. Arch Intern Med 1985; 145: 670–672.PubMedCrossRefGoogle Scholar
  46. 46.
    Baskin DH, Lax JD, Barenberg D: Shigella bacteremia in patients with the acquired immune deficiency syndrome. Am J Gastroenterol 1987; 82: 338–341.PubMedGoogle Scholar
  47. 47.
    Soave R, Danner RL, Honig CL, et al: Cryptosporidiosis in homosexual men. Ann Intern Med 1984; 100: 504–511.PubMedCrossRefGoogle Scholar
  48. 48.
    Pitlik SD, Fainstein V, Garza D, et al: Human cryptosporidiosis: Spectrum of disease. Arch Intern Med 1983; 143: 2269–2275.PubMedCrossRefGoogle Scholar
  49. 49.
    Current WL, Reese NC, Ernst JV, et al: Human cryptosporidsiosis in immunocompetent and immunodeficient persons. N Engl J Med 1983; 308: 1252–1257.PubMedCrossRefGoogle Scholar
  50. 50.
    Ma P, Soave R: Three-step stool examination for cryptosporidiosis in 10 homosexual men with protracted watery diarrhea. J Infect Dis 1983; 147: 824–828.PubMedCrossRefGoogle Scholar
  51. 51.
    Soave R, Armstrong D: Cryptosporidium and cryptosporidiosis. Rev Infect Dis 1986; 8: 1012–1023.PubMedCrossRefGoogle Scholar
  52. 52.
    Centers for Disease Control: Update: Treatment of cryptosporidiosis in patients with acquired immunodeficiency syndrome (AIDS). Morbid Mortal Week Rep 1984; 33: 117–119.Google Scholar
  53. 53.
    Portnoy D, Whiteside ME, Buckley E III, et al: Treatment of intestinal cryptospridiosis with spiramycin. Ann Intern Med 1984; 101: 202–204.PubMedCrossRefGoogle Scholar
  54. 54.
    Greene JB, Sidhu GS, Lewin S, et al: Mycobacterium avium-intracellulare: A cause of disseminated life-threatening infection in homosexuals and drug abusers. Ann Intern Med 1982; 97: 539546.Google Scholar
  55. 55.
    Levinson W, Bennetts RW: Cytomegalovirus colitis in acquired immunodeficiency syndrome-a chronic disease with varying manifestations. Am J Gastroenterol 1985; 80: 445–447.PubMedGoogle Scholar
  56. 56.
    Kalb RE, Grossman ME: Chronic perianal herpes simplex in immunocompormised hosts. Am J Med 1986; 80: 486–490.PubMedCrossRefGoogle Scholar
  57. 57.
    Frank D, Raicht RF: Intestinal perforation associated with cytomegalovirus infection in patients with acquired immunodeficiency syndrome. Am J Gastroenterol 1984; 79: 201–205.PubMedGoogle Scholar
  58. 58.
    Klein RS, Harris CA, Small CB, et al: Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984; 311: 354–358.PubMedCrossRefGoogle Scholar
  59. 59.
    Kotler DP, Gaetz HP, Lange M, et al: Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984; 101: 421–428.Google Scholar

Copyright information

© Springer Science+Business Media New York 1988

Authors and Affiliations

  • Richard B. Brown

There are no affiliations available

Personalised recommendations